Literature DB >> 28987733

How Inflammasomes Inform Adaptive Immunity.

Charles L Evavold1, Jonathan C Kagan2.   

Abstract

An immune response consists of a finely orchestrated interplay between initial recognition of potential microbial threats by the innate immune system and subsequent licensed adaptive immune neutralization. The initial recognition integrates environmental cues derived from pathogen-associated molecular patterns and cell-intrinsic damage-associated molecular patterns to contextualize the insult and inform a tailored adaptive response via T and B lymphocytes. While there are much data to support the role of transcriptional responses downstream of pattern recognition receptors in informing the adaptive immune response, markedly less attention has been paid to the role of post-translational responses to pathogen-associated molecular pattern and damage-associated molecular pattern recognition by the innate immune system, and how this may influence adaptive immunity. A well-characterized post-translational consequence of pattern recognition receptor signaling is the assembly of a multimeric signaling platform, termed the inflammasome, by members of the nucleotide-binding oligomerization domain (Nod), leucine-rich repeat-containing receptors (NLRs), and pyrin and HIN domain (PYHIN) families. Inflammasomes assemble in response to cytosolic perturbations, such as mitochondrial dysfunction and aberrant ion fluxes in the case of the canonical NLRP3 inflammasome or the presence of bacterial lipopolysaccharides in the case of the non-canonical inflammasome. Assembly of the inflammasome allows for the cleavage and activation of inflammatory caspases. These activated inflammatory caspases in turn cleave pro-form inflammatory cytokines into their mature bioactive species and lead to unconventional protein secretion and lytic cell death. In this review, we discuss evidence for inflammasome-mediated instruction and contextualization of infectious and sterile agents to the adaptive immune system.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  SMOC; TLR; adaptive immunity; inflammasomes; innate immunity

Mesh:

Substances:

Year:  2017        PMID: 28987733      PMCID: PMC5766381          DOI: 10.1016/j.jmb.2017.09.019

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  246 in total

1.  Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules.

Authors:  Espen S Baekkevold; Myriam Roussigné; Takeshi Yamanaka; Finn-Eirik Johansen; Frode L Jahnsen; François Amalric; Per Brandtzaeg; Monique Erard; Guttorm Haraldsen; Jean-Philippe Girard
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

2.  Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice.

Authors:  A Mencacci; A Bacci; E Cenci; C Montagnoli; S Fiorucci; A Casagrande; R A Flavell; F Bistoni; L Romani
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

3.  Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection.

Authors:  Nicole Schmitz; Michael Kurrer; Martin F Bachmann; Manfred Kopf
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  IL-1 beta-deficient mice are resistant to induction of experimental SLE.

Authors:  Elena Voronov; Molly Dayan; Heidy Zinger; Lubov Gayvoronsky; Jian-Ping Lin; Yoichiro Iwakura; Ron N Apte; Edna Mozes
Journal:  Eur Cytokine Netw       Date:  2006-06       Impact factor: 2.737

5.  Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18.

Authors:  Marco Tucci; Cosima Quatraro; Lucia Lombardi; Cecilia Pellegrino; Franco Dammacco; Franco Silvestris
Journal:  Arthritis Rheum       Date:  2008-01

6.  Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence.

Authors:  Olaf Gross; Hendrik Poeck; Michael Bscheider; Catherine Dostert; Nicole Hannesschläger; Stefan Endres; Gunther Hartmann; Aubry Tardivel; Edina Schweighoffer; Victor Tybulewicz; Attila Mocsai; Jürg Tschopp; Jürgen Ruland
Journal:  Nature       Date:  2009-04-01       Impact factor: 49.962

7.  Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activation.

Authors:  Jieling Yang; Yue Zhao; Jianjin Shi; Feng Shao
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

Review 8.  CD8(+) T cells: foot soldiers of the immune system.

Authors:  Nu Zhang; Michael J Bevan
Journal:  Immunity       Date:  2011-08-26       Impact factor: 31.745

9.  The NLRP3 Inflammasome Is a Pathogen Sensor for Invasive Entamoeba histolytica via Activation of α5β1 Integrin at the Macrophage-Amebae Intercellular Junction.

Authors:  Leanne Mortimer; France Moreau; Steve Cornick; Kris Chadee
Journal:  PLoS Pathog       Date:  2015-05-08       Impact factor: 6.823

10.  Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection.

Authors:  Marco A Ataide; Warrison A Andrade; Dario S Zamboni; Donghai Wang; Maria do Carmo Souza; Bernardo S Franklin; Samir Elian; Flaviano S Martins; Dhelio Pereira; George Reed; Katherine A Fitzgerald; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  PLoS Pathog       Date:  2014-01-16       Impact factor: 6.823

View more
  49 in total

1.  Topical Application of the Antimicrobial Agent Triclosan Induces NLRP3 Inflammasome Activation and Mitochondrial Dysfunction.

Authors:  Lisa M Weatherly; Hillary L Shane; Sherri A Friend; Ewa Lukomska; Rachel Baur; Stacey E Anderson
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

2.  Orchestration of human macrophage NLRP3 inflammasome activation by Staphylococcus aureus extracellular vesicles.

Authors:  Xiaogang Wang; William J Eagen; Jean C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-27       Impact factor: 11.205

3.  Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant.

Authors:  Jan Tavernier; Sarah Gerlo; Bram Van Den Eeckhout; Lien Van Hoecke; Elianne Burg; Sandra Van Lint; Frank Peelman; Niko Kley; Gilles Uzé; Xavier Saelens
Journal:  NPJ Vaccines       Date:  2020-07-23       Impact factor: 7.344

Review 4.  Inflammasomes and adaptive immune responses.

Authors:  Katherine A Deets; Russell E Vance
Journal:  Nat Immunol       Date:  2021-02-18       Impact factor: 25.606

5.  Role reversal: adaptive immunity instructs inflammasome activation for anti-viral defence.

Authors:  Rebecca C Coll
Journal:  EMBO J       Date:  2019-10-16       Impact factor: 11.598

Review 6.  Reconciling protective and pathogenic roles of the NLRP3 inflammasome in leishmaniasis.

Authors:  Valerie Harrington; Prajwal Gurung
Journal:  Immunol Rev       Date:  2020-06-20       Impact factor: 12.988

Review 7.  Inflammasomes: Threat-Assessment Organelles of the Innate Immune System.

Authors:  Charles L Evavold; Jonathan C Kagan
Journal:  Immunity       Date:  2019-08-28       Impact factor: 31.745

Review 8.  Gasdermin D activity in inflammation and host defense.

Authors:  Judy Lieberman; Hao Wu; Jonathan C Kagan
Journal:  Sci Immunol       Date:  2019-09-06

Review 9.  SAMHD1 Suppression of Antiviral Immune Responses.

Authors:  Shuliang Chen; Serena Bonifati; Zhihua Qin; Corine St Gelais; Li Wu
Journal:  Trends Microbiol       Date:  2018-10-15       Impact factor: 17.079

Review 10.  Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases.

Authors:  Falguni Baidya; Mariya Bohra; Aishika Datta; Deepaneeta Sarmah; Birva Shah; Priya Jagtap; Swapnil Raut; Ankan Sarkar; Upasna Singh; Kiran Kalia; Anupom Borah; Xin Wang; Kunjan R Dave; Dileep R Yavagal; Pallab Bhattacharya
Journal:  Immunology       Date:  2020-10-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.